Citadel Advisors
TLSA icon

Citadel Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Citadel Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-800
Closed -$864 – 15085
2025
Q1 		$864 Buy
+800
New +$782 ﹤0.01% 14206
2021
Q2 		– Sell
-19,300
Closed -$53K – 14437
2021
Q1 		$53K Buy
+19,300
New +$64K ﹤0.01% 12878

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return

Citadel Advisors's TLSA Position: Q1 2026 in Review

Citadel Advisors opened a new position in Tiziana Life Sciences (TLSA) in Q1 2026: 35,094 shares worth $41.1K. The stake represents ﹤0.01% of the portfolio and ranks #12479 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in TLSA as recently as Q2 2025.

Citadel Advisors first reported a position in TLSA in Q1 2019 and has held it in 9 quarters since. The position peaked at $314K in Q2 2025. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • Citadel Advisors held 35,094 shares of Tiziana Life Sciences worth $41.1K as of Q1 2026.
  • Tiziana Life Sciences was a new Citadel Advisors position in Q1 2026.
  • Tiziana Life Sciences made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12479 holding.
  • Citadel Advisors first reported a position in Tiziana Life Sciences in Q1 2019 and has held it in 9 quarters since.
  • Citadel Advisors's Tiziana Life Sciences position peaked at $314K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.